Cognitive function over time in the Alzheimer's disease anti-inflammatory prevention trial (ADAPT): Results of a randomized, controlled trial of naproxen and celecoxib
Barbara K. Martin, Christine Szekely, Jason Brandt, Steven Piantadosi, John C.S. Breitner, Suzanne Craft, Denis Evans, Robert Green, Michael Mullan
Dive into the research topics of 'Cognitive function over time in the Alzheimer's disease anti-inflammatory prevention trial (ADAPT): Results of a randomized, controlled trial of naproxen and celecoxib'. Together they form a unique fingerprint.